National Asset Management, Inc. Abbott Laboratories Transaction History

National Asset Management, Inc.

$3.82 Billion
Q2 2024

A detailed history of National Asset Management, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, National Asset Management, Inc. holds 58,722 shares of ABT stock, worth $6.92 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

58,722

Previous 64,704 9.25%

Holding current value

$6.92 Million

Previous $7.35 Million 17.04%

% of portfolio

0.16%

Previous 0.17%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 19, 2024	SELL	$100.73 - $112.44 $602,566 - $672,616	-5,982 Reduced 9.25%	58,722 $6.1 Million
Q1 2024 May 16, 2024	BUY	$109.52 - $120.96 $889,959 - $982,920	8,126 Added 14.36%	64,704 $7.35 Million
Q4 2023 Mar 15, 2024	SELL	$90.19 - $110.4 $732,883 - $897,110	-8,126 Reduced 12.56%	56,578 $6.23 Million
Q3 2023 Dec 01, 2023	SELL	$95.53 - $114.62 $13.1 Million - $15.8 Million	-137,628 Reduced 68.02%	64,704 $6.27 Million
Q2 2023 Jul 27, 2023	BUY	$100.78 - $112.29 $14.4 Million - $16.1 Million	143,082 Added 241.49%	202,332 $22.1 Million
Q1 2023 May 17, 2023	BUY	$96.86 - $114.01 $40,971 - $48,226	423 Added 0.72%	59,250 $6 Million
Q4 2022 Mar 15, 2023	SELL	$95.06 - $111.52 $100,668 - $118,099	-1,059 Reduced 1.77%	58,827 $6.46 Million
Q4 2022 Feb 21, 2023	SELL	$95.06 - $111.52 $41,351 - $48,511	-435 Reduced 0.72%	59,886 $6.58 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $1.76 Million - $2.04 Million	18,165 Added 43.09%	60,321 $5.84 Million
Q2 2022 Aug 12, 2022	SELL	$102.07 - $123.37 $84,616 - $102,273	-829 Reduced 1.93%	42,156 $4.58 Million
Q1 2022 May 02, 2022	SELL	$114.02 - $139.04 $326,325 - $397,932	-2,862 Reduced 6.24%	42,985 $5.09 Million
Q4 2021 Jan 28, 2022	BUY	$115.53 - $141.46 $102,128 - $125,050	884 Added 1.97%	45,847 $6.45 Million
Q3 2021 Nov 16, 2021	SELL	$116.66 - $129.06 $1.1 Million - $1.22 Million	-9,437 Reduced 17.35%	44,963 $5.31 Million
Q2 2021 Aug 10, 2021	SELL	$105.79 - $124.53 $312,821 - $368,235	-2,957 Reduced 5.16%	54,400 $6.31 Million
Q1 2021 May 13, 2021	SELL	$108.84 - $128.23 $995,994 - $1.17 Million	-9,151 Reduced 13.76%	57,357 $6.88 Million
Q4 2020 Feb 04, 2021	SELL	$105.0 - $114.42 $1.94 Million - $2.12 Million	-18,489 Reduced 21.75%	66,508 $7.28 Million
Q3 2020 Nov 09, 2020	SELL	$91.64 - $111.29 $13,012 - $15,803	-142 Reduced 0.17%	84,997 $9.25 Million
Q2 2020 Jul 31, 2020	BUY	$76.57 - $98.0 $2.79 Million - $3.57 Million	36,380 Added 74.61%	85,139 $7.79 Million
Q1 2020 May 06, 2020	BUY	$62.82 - $91.86 $302,478 - $442,305	4,815 Added 10.96%	48,759 $3.85 Million
Q4 2019 Feb 10, 2020	BUY	$78.51 - $87.4 $1.26 Million - $1.41 Million	16,078 Added 57.7%	43,944 $3.82 Million
Q3 2019 Nov 12, 2019	BUY	$81.84 - $88.74 $516,492 - $560,038	6,311 Added 29.28%	27,866 $2.33 Million
Q2 2019 Aug 05, 2019	BUY	$72.88 - $85.0 $77,908 - $90,865	1,069 Added 5.22%	21,555 $1.82 Million
Q1 2019 May 08, 2019	SELL	$66.22 - $80.06 $76,219 - $92,149	-1,151 Reduced 5.32%	20,486 $1.64 Million
Q4 2018 Feb 08, 2019	BUY	$65.56 - $74.27 $16,193 - $18,344	247 Added 1.15%	21,637 $1.57 Million
Q3 2018 Nov 08, 2018	BUY	$60.81 - $73.36 $45,546 - $54,946	749 Added 3.63%	21,390 $1.57 Million
Q2 2018 Oct 05, 2018	BUY	$57.57 - $63.54 $748 - $826	13 Added 0.06%	20,641 $1.26 Million
Q1 2018 May 15, 2018	SELL	$56.27 - $63.62 $45,747 - $51,723	-813 Reduced 3.79%	20,628 $1.24 Million
Q4 2017 Feb 15, 2018	BUY	$53.68 - $57.47 $6,871 - $7,356	128 Added 0.6%	21,441 $1.23 Million
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $43,254 - $48,276	900 Added 4.41%	21,313 $1.14 Million
Q2 2017 Aug 15, 2017	BUY	N/A	20,413	20,413 $993,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of National Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on National Asset Management, Inc. with notifications on news.

Account

National Asset Management, Inc. Abbott Laboratories Transaction History